Mucor and Aspergillus Maxillary Bone and Sinuses coinfection in a woman with Systemic Lupus Erythematosus: A Case Report
Novelty in Biomedicine,
Vol. 13 No. 1 (2025),
20 January 2025
,
Page 61-65
https://doi.org/10.22037/nbm.v13i1.43734
Abstract
Background: Mucorales and Aspergillus have invasive fungal infections with high mortality, mainly in immunocompromised and diabetic patients. The diagnosis is microbiological and pathological, with a strong clinical suspicion. The treatment is medical and surgical debridement. Invasive fungal coinfection by these two is reported as a case report. Here, we highlight the importance of considering the coinfection of Aspergillus and Mucor in the maxillary bone and paranasal sinuses in patients with systemic lupus erythematosus (SLE).
Cases Report: A 38-year-old woman had a fever and toothache 1.5 months before and had been treated for a dental abscess, which continued to fever, epistaxis, teeth out spontaneously, left Bell’s Palsy, and swelling in the left side of her face. She had a history of immunosuppressive therapy and steroid-induced hyperglycemia for SLE. The PNS CT Scan found increased mucosal thickness of the left maxilla and sphenoid sinuses. Extensive debridement was done. Pathologic study of debrided samples showed coinfection of invasive mucormycosis and aspergillosis. She was treated with liposomal amphotericin B and voriconazole with complete recovery without recurrence after a one-year follow-up.
Conclusion: In mucor and aspergillus coinfection, no one should be missed at first and treated by specific antifungal amphotericin B, with no time-wasting for a better prognosis.
- Mucor
- Aspergillus
- Coinfection
- Maxillary bone
- Paranasal sinuses
- Systemic lupus erythematosus
How to Cite
References
Hu ZM, Wang LL, Zou L, Chen ZJ, Yi Y, Meng QB, Feng Y. Coinfection pulmonary mucormycosis and aspergillosis with disseminated mucormycosis involving gastrointestinalin in an acute B-lymphoblastic leukemia patient. Braz J Microbiol. 2021;52(4):2063-8.
Petrikkos G, Skiada A, Lortholary O, Roilides E, Walsh TJ, Kontoyiannis DP. Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis. 2012;54(Suppl 1):S23–34.
Ge Song. Guanzhao Liang. Weida Liu, Fungal Co-Infections Associated with Global COVID-19 Pandemic: A Clinical and Diagnostic Perspective from China, Mycopathologia; 2020;185(4):599-606.
Klimko NN, Khostelidi SN, Volkova AG, Popova MO, Bogomolova TS, Zuborovskaya LS, et al. Mucormycosis in haematological patients: case report and results of prospective study in Saint Petersburg, Russia. Mycoses. 2014;57(Suppl 3):91–6.
Cadena J, Thompson GR, Patterson TF. Invasive aspergillosis: current strategies for diagnosis and management. Infect Dis Clin North Am. 2016; 30(1):125-42.
Mandel, Douglas & Bennett. Principles and Practice of Infectious Diseases. 9th ed. Philadelphia: Churchill Livingston;2019:3112-25.
Boroujeni ZB, Shamsaei S, Yarahmadi M, Getso MI, Salimi-Khorashad A, Haghighi L, et al. Distribution of invasive fungal infections: molecular epidemiology, etiology, clinical conditions, diagnosis and risk factors: a 3-year experience with 490 patients under intensive care. Microb Pathog 2020;104616
S. Zayet, A. Zaghdoudi, L. Ammari, B. Kilani,Tiouiri Benaissa H. Cerebro-rhino-orbital mucormycosis and aspergillosis coinfection in a patient with diabetes mellitus: a case report, ID Cases, 23 (2021), p. e01022,
A.H. Mahadevaiah, N. Rajagopalan, M. Patil, S C; Coinfection of pulmonary mucormycosis and aspergillosis presenting as bilateral vocal cord palsy, BMJ Case Rep, 2013 (2013), Article bcr 2013009615.
Singh A, Mohanty A, Jha S, Gupta P, Kaistha N. Concomitant Mucormycosis with Aspergillosis in Patients with Uncontrolled Diabetes Mellitus: A Case Series.J Clin of Diagn Res.2021; 15(2):DR01-DR03.
Rit K, Saha R, Dey R, Barik G. Rhino-oculo-cerebral aspergillus and mucor co-infections in an immunocompromised patient with type 2 diabetes mellitus. Med J Dr Patil Univ 2014;7(4):486
Gangneux JP, Bougnoux ME, Dannaoui E, Cornet M, Zahar JR. Invasive fungal diseases during COVID-19: we should be prepared. J Mycol Med. 2020.
Paul M, Sasidharan J, Taneja J, Chatterjee K, Abbas SZ, Chowdhury V, Das A. Invasive Mucormycosis and Aspergillosis Coinfection Associated with Post-COVID-19 Pneumonia in a Tertiary Care Hospital. Med Mycol J. 2022;63(3):59-64.
Chiurlo M, Mastrangelo A, Ripa M, Scarpellini P; Invasive fungal infections in patients with COVID-19: a review on pathogenesis, epidemiology, clinical features, treatment, and outcomes, New Microbiol. 2021 Apr;44(2):71-83.
Fallah F, Lotfali E, Azimi L, Khodaei H, Rajabnejad M, et al. The First Fungal Identification from Mini-BAL of Critical COVID-19 Patients. Arch Pediatr Infect Dis. 2023;11(4):e136153.
- Abstract Viewed: 136 times
- pdf Downloaded: 126 times